Come to think of it I dont recall any bio trial result being a proper success recently...
Either they fail and report bad outcomes or they report 'successful outcomes' but market doesnt care for a myriad of reasons some specific to the company itself.
Think there's a general sentiment of fear and de-risking perhaps.
Ann: IHL-42x (OSA) accelerated FDA approval pathway, page-22
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)